AI Insight
This multi-country analysis of population-based studies in industrialized nations found that older adults with obesity now have blood pressure and non-HDL cholesterol levels increasingly similar to those with normal BMI, likely due to greater use of antihypertensive and lipid-lowering medications. However, significant variation exists between countries in this convergence pattern. Young adults with obesity continue to show substantially higher metabolic risk compared to their normal-weight peers.
Why it matters
The findings suggest that pharmacological interventions are effectively managing some metabolic risk factors in older adults with obesity, though this may mask underlying metabolic dysfunction. The persistent elevated risk in young adults with obesity highlights the need for early prevention strategies and indicates that medication alone may not fully address obesity-related health risks across all age groups.
Understand the Science
In industrialised countries, blood pressure and non-HDL cholesterol in older adults with obesity are increasingly similar to those with normal BMI, with higher use of antihypertensive and lipid-lowering medicines a possible driver of this convergence. There is nonetheless heterogeneity across countries in the extent of convergence. Young adults with obesity remain metabolically at higher risk than their counterparts with normal weight.